GlassScriptPhysician profile
Molly Mayerle Conklin
NPI 1760142210
$1,804.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $476 · 2023: $779 · 2024: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $241.02 | 2023 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Gilead Sciences, INC. | $219.96 | 2024 | Epclusa |
| W. L. Gore & Associates, INC. | $207.40 | 2024 | Gore Cardioform Septal Occluder |
| Teva Pharmaceuticals USA, INC. | $205.61 | 2022-2023 | Uzedy |
| Astrazeneca Pharmaceuticals LP | $125.04 | 2022 | |
| Xeris Pharmaceuticals, INC. | $122.33 | 2024 | Gvoke Hypopen |
| Genzyme Corporation | $119.02 | 2023 | |
| Inspire Medical Systems, INC. | $118.62 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $98.88 | 2022 | |
| Alexion Pharmaceuticals, INC. | $98.44 | 2023 | |
| Idorsia Pharmaceuticals US INC | $96.19 | 2022 | |
| Sk Life Science, INC. | $60.65 | 2022 | |
| Coloplast Corp | $53.81 | 2023 | Titan, Altis |
| Medtronic, INC. | $37.82 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Conklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.